Oral Propranolol Therapy For A Pediatric Choroidal Hemangioma
Published 2023 - 41st Congress of the ESCRS
Reference: PO1063 | Type: Free paper | DOI: 10.82333/mf0r-df05
Authors: Mahmoud Mustafa Mahmoud Mustafa* 1 , Ghada Elnady 1
1Pediatric ophthalmology ,Alexandria General Ophthalmology Hospital,Alexandria,Egypt
Purpose
To evaluate the effectiveness of oral propranolol in the treatment of exudative retinal detachment secondary to choroidal heamangiomas.
Setting
A case Report
Methods
We administered oral propranolol at a dose of 1.5mg/kg/day to 8 years girl with circumscribed choroidal heamangioma and exudative retinal detachment
We then evaluated the visual acuity, indirect ophthalmoscope, fundus photo,ultrasound at regular intervals and compared changes from the base line assessment.
Results
The study showed that the RD slowly resolved over 3 months with improvement of the visual acuity and the retina remained attached at 3 months follow up.
Conclusions
Oral propranolol can prove to be an effective non invasive therapy in children having choroidal hemangioma with exudative retinal detachment.